Atea Pharmaceuticals director Polly Murphy buys $25,446 in stock

Polly Murphy, a director at Atea Pharmaceuticals, has made a personal investment in the company by purchasing shares valued at $25,446. This transaction reflects her confidence in the company's future prospects. The acquisition of stock was reported in a filing with the appropriate regulatory authorities, which is standard practice for corporate insiders.

Read More